9789 related articles for article (PubMed ID: 1480041)
1. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG; Krutzsch HC; Liotta LA
Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG; Krutzsch HC; Liotta LA
J Biol Chem; 1989 Oct; 264(29):17374-8. PubMed ID: 2793861
[TBL] [Abstract][Full Text] [Related]
3. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
Moore WG; Birkedal-Hansen B; Pierson M; Birkedal-Hansen H
Matrix Suppl; 1992; 1():319-20. PubMed ID: 1480050
[No Abstract] [Full Text] [Related]
4. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
Banda MJ; Howard EW; Herron GS; Apodaca G
Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
6. A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1.
Agrez MV; Meldrum CJ; Sim AT; Aebersold RH; Clark IM; Cawston TE; Burns GF
Biochem Biophys Res Commun; 1995 Jan; 206(2):590-600. PubMed ID: 7826376
[TBL] [Abstract][Full Text] [Related]
7. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
8. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
Ward RV; Hembry RM; Reynolds JJ; Murphy G
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
[TBL] [Abstract][Full Text] [Related]
9. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
10. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
11. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Moll UM; Youngleib GL; Rosinski KB; Quigley JP
Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
[TBL] [Abstract][Full Text] [Related]
12. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
13. Latent collagenase and gelatinase from human neutrophils and their activation.
Tschesche H; Knäuper V; Krämer S; Michaelis J; Oberhoff R; Reinke H
Matrix Suppl; 1992; 1():245-55. PubMed ID: 1480034
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
15. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
[TBL] [Abstract][Full Text] [Related]
16. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
Li L; Akers K; Eisen AZ; Seltzer JL
Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
[TBL] [Abstract][Full Text] [Related]
17. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
18. Directed mutagenesis reveals that two histidines in tissue inhibitor of metalloproteinase-1 are each essential for the suppression of cell migration, invasion, and tumorigenicity.
Walther SE; Denhardt DT
Cell Growth Differ; 1996 Nov; 7(11):1579-88. PubMed ID: 8930408
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression, and characterization of chicken tissue inhibitor of metalloproteinase-2 (TIMP-2) in normal and transformed chicken embryo fibroblasts.
Aimes RT; Li LH; Weaver B; Hawkes S; Hahn-Dantona EA; Quigley JP
J Cell Physiol; 1998 Mar; 174(3):342-52. PubMed ID: 9462696
[TBL] [Abstract][Full Text] [Related]
20. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
